Odyssey Health, Inc.
Income Statement
| Line Item | Jul 2020 | Apr 2020 | Jan 2020 | Oct 2019 | Jul 2019 | Apr 2019 | Jan 2019 | Oct 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $0 | — | — | — | — | — | — |
| SG&A Expense | $1.2M | $867.7K | $499.8K | $1.3M | $23.2M | $45.2K | $89.8K | $52.4K |
| Operating Income | $-1.2M | $-867.7K | $-499.8K | $-1.3M | $-23.4M | $-45.2K | $-89.8K | $-52.4K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | $175.5K | $131.6K | $101.2K | $93.9K | $18.9K | $17.6K | $16.7K | $17.1K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-1.3M | $-999.3K | $-600.9K | $-1.4M | $-23.2M | $-62.8K | $-106.5K | $-69.5K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.34 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | $-0.01 | $-0.01 | $-0.02 | — | — | — | — |
| Shares Outstanding (Basic) | 87.1M | 87.2M | 87.1M | 87.0M | 69.9M | 68.7M | 64.7M | 61.4M |
| Shares Outstanding (Diluted) | 87.1M | 87.2M | 87.1M | 87.0M | 69.9M | 68.7M | 64.7M | 61.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |